Abediterol

DB12100InvestigationalSmall molecule

Abediterol has been used in trials studying the treatment of Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Chronic Obstructive Pulmonary Disease (COPD) and Asthma.

Mechanism: Pharmacologically active on Beta-2 adrenergic receptor
Curator reviewed
Formula / weight: C₂₅H₃₀F₂N₂O₄ · 460.522 g/mol (avg)
Code names: LAS100977

Resolves to

Compound

UNIIQXA167CM6FCAS915133-65-2ChEMBLCHEMBL3039530ChEBI142077PubChem11962616

Structure

InChIKeySFYAXIFVXBKRPK-QFIPXVFZSA-NSMILESO[C@@H](CNCCCCCCOCC(F)(F)C1=CC=CC=C1)C1=C2C=CC(=O)NC2=C(O)C=C1

Targets

P07550ADRB2

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

789Drug interactionsStructured to mechanism, not free text

5Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Abediterol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account